Evidence map›Paper›PMID 41244978›Full record

ArticleASM case reports2025

Divisha Sharma, Scott R Curry, Courtney E Harris, Alexandra Mills, Rachel Burgoon, Drew W Charles

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ASM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. DisseminatedMedical mycology case reports · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Divisha SharmaDivision of Infectious Disease, Medical University of South Carolina, Charleston, South Carolina, USA.
Scott R CurryDivision of Infectious Disease, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID https://orcid.org/0000-0003-0961-9670
Courtney E HarrisDivision of Infectious Disease, Medical University of South Carolina, Charleston, South Carolina, USA.
Alexandra MillsDivision of Infectious Disease, Medical University of South Carolina, Charleston, South Carolina, USA.
Rachel BurgoonDepartment of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, USA.
Drew W CharlesDivision of Infectious Disease, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID https://orcid.org/0009-0008-0429-9798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Summary: We present a case of an immunocompromised male who underwent heart transplantation with subsequent syndrome of chronic pneumonia. Imaging suggested an atypical pulmonary process prompting empiric initiation of isavuconazonium. Despite treatment, the patient's condition worsened, and fungal culture from sputum and bronchoalveolar lavage both grew Conclusion: This case highlights the limited experience and clinical failure of isavuconazonium as empiric therapy for

Indexed as

isavuconazolepneumoniatransplantVerruconis gallopava

Identifiers

PMID41244978
PMCPMC12530243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.